These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3024829)

  • 21. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA
    Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer.
    Giaccone G; Huizing M; Postmus PE; ten Bokkel Huinink WW; Koolen M; van Zandwijk N; Vermorken JB; Beijnen JH; Dalesio O; Pinedo HM
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):78-82. PubMed ID: 7544030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.
    Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG; Ordónez A; Jalón JI; Barón MG
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA; Latreille J; Paul K; Eisenhauer E
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
    Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
    J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of VM-26 as a single agent in the treatment of renal carcinoma.
    Hire EA; Samson MK; Fraile RJ; Baker LH
    Cancer Clin Trials; 1979; 2(4):293-5. PubMed ID: 394865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
    Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of teniposide in advanced breast cancer.
    Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
    Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I study of oral teniposide (VM-26).
    Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
    Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
    J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
    Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
    Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
    Jankowski RP; Vahrson H
    Med Klin; 1977 Dec; 72(49):2122-6. PubMed ID: 337083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin and teniposide chemotherapy for advanced non-small cell lung cancer.
    Iberti V; Donadio M; Giaccone G
    Eur J Cancer; 1991; 27(9):1104-6. PubMed ID: 1659849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of teniposide in adenocarcinoma of the lung.
    Sørensen JB; Bach F; Dombernowsky P; Hansen HH
    Cancer Chemother Pharmacol; 1991; 27(6):487-9. PubMed ID: 2013120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
    Cox EB; Vogel CL; Carpenter JT; Raney M
    Invest New Drugs; 1988 Apr; 6(1):37-9. PubMed ID: 3410666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
    Samson MK; Baker LH; Talley RW; Fraile RJ
    Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.